Lonza at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Lonza takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on the trade-offs of drug development and manufacturing, from balancing speed, risk and future value on the way to an IND to scaling biologics production. The manufacturing session, shared with Lundbeck, looks at how biopharma is rethinking launches, partnerships and resilience.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Lonza Basel, Switzerland | ◆Platinum Sponsor |
Contract development and manufacturing organization for biologics, small molecules, and cell and gene therapies. | Panel Mon Nov 9 15:30–15:55 Beyond the Race to IND: Balancing Speed, Risk and Future Value When racing to first human trials pays off for a biotech, and when that speed creates risks for manufacturing and growth later on. Panel Tue Nov 10 15:00–15:25 Scaling Biologics Manufacturing in a Changing World: How Biopharma is Rethinking Launches, Partnerships and Resilience How political uncertainty and trade shifts are changing how drug companies pick outside manufacturers, including whether to produce closer to home. |
Instantly find 20 buyers from Lonza
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction